These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Live virus vaccines for use in animals. Bostock CJ Dev Biol Stand; 1995; 84():41-8. PubMed ID: 7796966 [No Abstract] [Full Text] [Related]
3. Control of pediatric viral diseases: past successes and future prospects. Chanock RM Pediatr Res; 1990 Jun; 27(6 Suppl):S39-43. PubMed ID: 2113272 [No Abstract] [Full Text] [Related]
4. [Use of genetic engineering methods to create viral vaccines]. Tatarov G Vet Med Nauki; 1987; 24(1):88-92. PubMed ID: 3303657 [No Abstract] [Full Text] [Related]
5. [Viruses and gene engineering]. Tikhonenko TI Vestn Akad Med Nauk SSSR; 1983; (12):67-75. PubMed ID: 6198816 [No Abstract] [Full Text] [Related]
6. [Problems and concepts of active immunologic prevention of human virus diseases]. KaĆtoch M Przegl Epidemiol; 1985; 39(3-4):354-62. PubMed ID: 3832169 [No Abstract] [Full Text] [Related]
7. Genetically engineered vaccines: problems and promises. Brown F; Dougan G; Snary D Microbiol Sci; 1984 Aug; 1(5):123-7. PubMed ID: 6444113 [TBL] [Abstract][Full Text] [Related]
8. [Virology. The art of controlling the geniality which even the smallest contagions show]. Norrby E Lakartidningen; 1997 Jun; 94(25):2357-8, 2362-4. PubMed ID: 9229654 [No Abstract] [Full Text] [Related]
9. New advances in animal and human virus vaccines. Rowlands DJ Adv Biotechnol Processes; 1986; 6():253-85. PubMed ID: 3535833 [No Abstract] [Full Text] [Related]
10. [Immunization and prevention of infectious diseases of children]. Ueda K Fukuoka Igaku Zasshi; 1984 Sep; 75(9):520-3. PubMed ID: 6097523 [No Abstract] [Full Text] [Related]
11. Engineering attenuated virus vaccines by controlling replication fidelity. Vignuzzi M; Wendt E; Andino R Nat Med; 2008 Feb; 14(2):154-61. PubMed ID: 18246077 [TBL] [Abstract][Full Text] [Related]
12. [Research and development strategies, examples among new vaccines]. Denis F; Ploy MC Ann Pharm Fr; 2009 May; 67(3):198-202. PubMed ID: 19446670 [TBL] [Abstract][Full Text] [Related]
13. Program for accelerated development of new viral vaccines. Jordan WS Prog Med Virol; 1988; 35():1-20. PubMed ID: 3051131 [No Abstract] [Full Text] [Related]
14. Recombinant viral vector vaccines for the veterinary use. Yokoyama N; Maeda K; Mikami T J Vet Med Sci; 1997 May; 59(5):311-22. PubMed ID: 9192350 [TBL] [Abstract][Full Text] [Related]
16. Viral vectors for use in the development of biodefense vaccines. Lee JS; Hadjipanayis AG; Parker MD Adv Drug Deliv Rev; 2005 Jun; 57(9):1293-314. PubMed ID: 15935875 [TBL] [Abstract][Full Text] [Related]
17. Vaccines, cells and nucleic acids. Zuckerman AJ; Deinhardt F Bull World Health Organ; 1990; 68(2):139-41. PubMed ID: 2364474 [No Abstract] [Full Text] [Related]